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Objectives:Either maternal gestational diabetes mellitus (GDM) or hypertensive disorder
of pregnancy (HDP) is associated with an increased risk of obesity in the offspring.
However, their joint associations with obesity in offspring remain unclear. We investigated
the joint associations of maternal GDM and HDP with childhood overweight in offspring.
Methods: We performed a large study in 1967 mother-child pairs. Maternal GDM was
diagnosed according to the 1999 World Health Organization (WHO) criteria. HDP was
defined as self-reported doctor-diagnosed hypertension or treatment of hypertension
(including gestational hypertension, preeclampsia, sever preeclampsia or eclampsia) after
20 weeks of gestation on the questionnaire. Body mass index (BMI) for age Z-score and
childhood overweight were evaluated according to WHO growth reference. We used
the general linear models to compare children’s Z score for BMI and logistic regression
models to estimate odds ratios of childhood overweight according to maternal different
status of GDM and HDP.
Results: Offspring of mothers with both GDM and HDP had a higher BMI for age Z-score
(0.63 vs. 0.03, P < 0.001) than children born to normotensive and normoglycemic
pregnancy. After adjustment for maternal and children’s major confounding factors, joint
GDM and HDP were associated with increased odds ratios of offspring’s overweight
compared with normotensive and normoglycemic pregnancy (2.97, 95% confidence
intervals [CIs] 1.65–5.34) and GDM alone (2.06, 95% CIs 1.20–3.54), respectively.
After additional adjustment for maternal pre-pregnancy BMI and gestational weight
gain, joint maternal GDM, and HDP was still associated with an increased risk of
offspring’s overweight compared with the maternal normotensive, and normoglycemic
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group but became to have a borderline increased risk compared with the maternal GDM
alone group.
Conclusions: Maternal GDM alone or joint GDM and HDP were associated with
increased ratios of offspring’s overweight.
Keywords: gestational diabetes mellitus, hypertensive disorders of pregnancy, overweight, obesity, childhood
INTRODUCTION
Children with overweight and obesity are more likely to
be affected by obesity into adulthood and develop non-
communicable diseases including metabolic syndrome,
cardiovascular diseases, and type 2 diabetes (1–3). The
prevalence of obesity among children has been increasing
globally in the past 25 years (4). In China, the prevalence of
overweight and obesity among preschoolers reached 10.1% in
2010, and obesity was much worse in children than in adolescents
(5, 6). China now has the largest number of children with obesity
in the world (4).
Changes in children’s behaviors, such as unhealthy eating
habit, lacking moderate-to-vigorous physical activity, and
increasing sedentary time, mainly account for the increasing
prevalence of childhood obesity (7–9). Other factors, such
as genetic susceptibility, socioeconomic inequalities, maternal
education, children’s sleep disturbance, neonatal macrosomia,
may also play an important role in obesity formation (8–11).
Recent studies have indicated that maternal metabolic disorders
during pregnancy, such as gestational diabetes mellitus (GDM),
and hypertensive disorder of pregnancy (HDP), were associated
with an increased risk of obesity in children over 5 years old.
Several but not all studies have found that maternal GDM was
positively associated with general overweight/obesity, central
obesity, and subcutaneous adiposity (skinfold thickness) in the
offspring after 5 years old (12–17). Meanwhile, researchers
pointed out that maternal HDP was associated with a greater
risk of childhood overweight or obesity (18–20). A previous
study from our team also demonstrated that maternal HDP
was a risk factor for childhood overweight or obesity in the
offspring of mothers with GDM (21). Nevertheless, it is unclear
whether GDM concomitant with HDP represents an extra higher
risk factor for obesity in offspring. We aimed to examine the
joint association of maternal GDM and HDP with children’s
overweight among 1,967 mother-child pairs, including 1,263
mothers with GDM, and 704 without GDM.
MATERIALS AND METHODS
GDM Screening Process
Tianjin is the fourth largest city in China, only 30-min distance by
train from Beijing. There are six central districts in Tianjin with
about 4.3 million residents. In 1999, the Tianjin Women’s and
Children’s Health Center launched an urban universal screening
of GDM using the 1999 World Health Organization (WHO)’s
criteria in all six central districts. The screening rate was reported
to be >91% between 1999 and 2008 (22). We first invited all
pregnant women (at their 26–30 gestational weeks) to participate
in the 1-h 50-g glucose screening test in their community health
centers. Then, those with glucose reading ≥7.8 mmol/L were
referred to the Tianjin Women’s and Children’s Health Center
to undergo a 2-h oral glucose tolerance test (OGTT) with 75-
g glucose load. If the pregnant women met the 1999 WHO’s
criteria of diabetes (fasting glucose ≥7 mmol/L or 2-h glucose
≥11.1mmol/L), or impaired glucose tolerance (IGT) (2-h glucose
≥7.8 mmol/L and <11.1 mmol/L), they would be diagnosed as
GDM (23).
Study Population
Totally 76,325 women were screened from 2005 to 2009,
among whom 4,644 women were diagnosed as GDM, and
71,681 were free of GDM. We invited all 4,644 women with
GDM to participate in the Tianjin Gestational Diabetes Mellitus
Prevention Program (TGDMPP). From August 2009 to July
2011, a total of 1,263 women with GDM and their children
finished the baseline survey. There were no differences at 26–30
gestational weeks OGTT test in age (28.9 vs. 28.7 years), fasting
glucose (5.34 vs. 5.34 mmol/l), 2-h glucose (9.23 vs. 9.16 mmol/l),
and the prevalence of IGT (90.9 vs. 91.8%) and diabetes (9.1 vs.
8.2%) between the returned and unreturned GDM women. We
randomly chose and recruited 704 non-GDMmother-child pairs,
with age and sex frequency-matched to children of GDMmothers
at 1–2 years after the baseline survey of GDMmother-child pairs.
This study was carried out in accordance with the
recommendations of the Human Subjects Committee of
Tianjin Women’s and Children’s Health Center with written
informed consent from all subjects. All subjects gave written
informed consent in accordance with the Declaration of Helsinki.
The protocol was approved by the Human Subjects Committee
of Tianjin Women’s and Children’s Health Center.
Questionnaires and Measurements
A self-administered questionnaire was implemented to
collect mothers’ information, including socio-demographic
characteristics, such as age, education (<13 years, 13–16 years,
and ≥16 years), history of GDM and its treatment during
pregnancy; pregnancy outcomes (pre-pregnancy weight, weight
gain during pregnancy, gestational age, etc.); and lifestyle in
the past year, such as smoking status. HDP was defined as
self-reported doctor-diagnosed hypertension or treatment of
hypertension (including gestational hypertension, preeclampsia,
sever preeclampsia or eclampsia) after 20 weeks of gestation on
the questionnaire (8). Children’s information was collected by
another questionnaire completed by their mothers, including
children’s general information, such as sex, birth date, age, birth
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weight, birth length, lactation (exclusive formula, mixed, or
exclusive breast) and lactation duration; history of diseases, and
medication; dietary habits [using a validated food frequency
questionnaire [FFQ]] (24); and routine activities (indoor and
outdoor activities, screening watching time, and sleep duration)
(25). Macrosomia was defined when birth weight ≥4,000 g.
All mother-child pairs underwent a physical examination.
Using the standardized protocol, all participants’ height and
weight were measured in light indoor clothing and without shoes
by trained research doctors. Bodymass index (BMI) was obtained
by dividing weight in kilograms by the square of height in meters.
All mothers’ pre-pregnancy BMI used their self-reported pre-
pregnancy weight and their measured height. Children’s BMI
calculation used their body weight and height examined in the
study visit. Children’s Z scores for BMI-for-age were calculated
based on theWHOgrowth reference (26, 27). Children’s BMIwas
classified as normal weight, BMI <85th percentiles; overweight,
85th percentile≤ BMI<95th percentile; and obesity, BMI≥95th
percentile, according to the WHO age-, and sex-specific growth
reference (26, 27).
Statistical Analysis
Differences in the general characteristics (continuous and
categorical variables) of both mothers and children according to
maternal different status of GDM and HDP were tested using the
univariate analysis of variance or chi-square test. We used the
general linear models.
to compare children’s Z scores for BMI and used logistic
regression models to estimate odds ratios of childhood
overweight according to maternal different status of GDM and
HDP. All analyses were adjusted for maternal age, gestational
age, education, smoking status, history of treatment of GDM, and
HDP, children’s sex, age, birth weight, and feeding status (Model
1), and then children’s lifestyles including outdoor physical
activity time, screen watching time, sleep time, daily energy
intake, energy from fat and dietary fiber intake (Model 2), and
further for maternal pre-pregnancy BMI and gestational weight
gain (Model 3). All the statistical analyses were performed with
SPSS 25.0 for windows software package (IBM SPSS statistics 25)
and SAS Proprietary Software 9.4 (SAS Institute Inc., Cary, NC,
USA). Two-sided P< 0.05 was considered statistically significant.
RESULTS
As shown in Table 1, there were significant differences in
maternal age at delivery, pre-pregnancy BMI, gestational weight
gain, gestational age at delivery, and education among 4 different
groups (all P < 0.05). There were also differences in children’s
age, birth weight, outdoor activity time, screen watching time,
Z score for BMI-for-age, prevalence of overweight/obesity, and
daily energy intake from fat according to various maternal GDM
and HDP status (P < 0.001).
In comparison with children born to normotensive and
normoglycemic pregnancy, offspring of mothers with HDP
alone, GDM alone, and concomitant GDM and HDP had higher
levels of Z score for BMI-for-age after adjustment for maternal
age at delivery, gestational age at delivery, education, current
smoking, history of treatment of GDM and HDP, and children’s
age, sex, birth weight, and feeding status (Model 1, Table 2).
After further adjustment for children’s lifestyle factors, maternal
pre-pregnancy BMI, and gestational weight gain, the difference
of Z score for BMI was still significant among children who
born to mothers with GDM alone and concomitant GDM and
HDP, but no longer significant among children born to HDP
pregnancy alone, compared with those born to normotensive and
normoglycemic mothers during pregnancy.
Compared with children born to normotensive and
normoglycemic pregnancy, multi-variable (maternal age,
gestational age, education and smoking status, history of
treatment of GDM, and HDP, children’s sex, age, birth weight,
and feeding status) adjusted odds ratios (95% confidence
intervals [95% CI]) of overweight among children who born
to mothers with HDP alone, with GDM only, and with both
GDM and HDP were 2.61 (95% CI 0.98–6.93), 1.51 (95% CI
1.17–1.95), and 3.11 (95% CI 1.78–5.43), respectively (Model
1, Table 3). After additional adjustment for children’s lifestyle
factors, maternal pre-pregnancy BMI, and gestational weight
gain, children who born to mothers with GDM only or with both
GDM and HDP still had significantly increased odds ratios of
overweight compared with children who born to mothers with
normotension and normoglycaemia during pregnancy (Model
2-3, Table 3). There was no difference in odds ratios of childhood
overweight between children who born to mothers with HDP
only and children who born to mothers with GDM only.
Children who were born to mothers with joint GDM and HDP
had ∼1-fold higher multivariable-adjusted risk of overweight
compared with children who were born to mothers with GDM
only, but this association changed to borderline significance
after additional adjustment for maternal pre-pregnancy BMI and
gestational weight gain.
DISCUSSION
The present study indicated that maternal GDM alone or joint
GDM and HDP was associated with an increased Z score
for BMI-for-age and a higher risk of childhood overweight in
offspring. Concomitant of maternal GDM and HDP showed an
additionally higher risk for offspring’s overweight than maternal
GDM alone in offspring, but this association was not fully
independent of maternal pre-pregnancy BMI and gestational
weight gain.
Maternal GDM and HDP are two common complications
during pregnancy, and are associated with adverse pregnant
outcomes and exert long-term effect on their children (12, 28).
Most but not all studies have indicated that children born to
mothers with GDM are at higher risk of overweight or obesity
compared with those born to mothers with normal glucose
during pregnancy (15, 29–31). Studies on maternal HDP with
children’s obesity were controversial. Most studies demonstrated
that maternal HDP was associated with elevated BMI or an
increased risk for children’s overweight and obesity (18–21).
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TABLE 1 | Maternal and child characteristics according to maternal gestational diabetes and hypertensive disorders of pregnancy.
Non-GDM GDM P-value
Non-HDP HDP Non-HDP HDP
Numbers of subjects 677 27 1172 91
Maternal characteristics
Age at delivery, years 32.9 ± 2.84 32.9 ± 2.68 33.3 ± 3.49 33.8 ± 3.59 0.032
Pre-pregnancy BMI, kg/m2 21.4 ± 2.96 22.2 ± 3.04 22.9 ± 3.24 25.1 ± 3.64 < 0.001
Gestational weight gain, kg 18.2 ± 6.67 21.3 ± 6.14 16.6 ± 5.87 19.0 ± 7.01 < 0.001
Gestational age at delivery, weeks 39.1 ± 1.48 38.4 ± 1.76 39.0 ± 1.48 38.6 ± 1.77 0.001
Education, % < 0.001
<13 years 10.6 3.7 21.9 29.7
13–16 years 74.9 88.9 70.5 64.8
≥16 years 14.5 7.4 7.6 5.5
Current smoker, % 4.1 0 1.9 3.3 0.011
Insulin treatment of GDM, % - - 4.4 5.5 < 0.001
Anti-hypertensive therapy of HDP, % - 40.7 - 28.6 < 0.001
Child characteristics
Boy, % 52.0 63.0 52.3 62.6 0.43
Age, years 5.25 ± 1.20 5.41 ± 1.31 4.60 ± 2.18 4.23 ± 2.24 < 0.001
Birth weight, gram 3,425 ± 449 3,080 ± 583 3,540 ± 517 3,619 ± 613 < 0.001
Macrosomia 11.2 7.4 19.1 28.6 < 0.001
Mode of infant feeding, % 0.40
Exclusive breastfeeding 42.7 29.6 44.1 27.5
Exclusive formula feeding 43.7 59.3 42.1 49.5
Mixed feeding 13.6 11.1 13.8 23.1
Outdoor activity, hours/day 1.04 ± 0.63 0.98 ± 0.54 1.41 ± 0.79 1.41 ± 0.90 < 0.001
Screen watching time, hours/day 0.93 ± 0.76 0.96 ± 0.73 1.13 ± 0.87 1.35 ± 1.05 < 0.001
Sleeping time, % 0.53
≤8 h/day 10.3 3.7 12.5 20.9
9–10 h/day 66.8 81.5 58.8 52.7
≥11 h/day 22.9 14.8 28.7 26.4
BMI, kg/m2 15.6 ± 2.13 16.5 ± 3.51 16.2 ± 2.43 17.0 ± 2.93 < 0.001
Z score for BMI-for-age −0.01 ± 1.23 0.43 ± 1.68 0.28 ± 1.28 0.77 ± 1.66 < 0.001
Prevalence of overweight/obesity, % 17.0 25.9 23.8 36.3 < 0.001
Energy intake, kcal/day 1,526 ± 424 1,688 ± 563 1,259 ± 568 1,220 ± 612 < 0.001
Energy intake from fat, % 25.7 ± 5.40 25.8 ± 5.99 32.4 ± 21.7 33.1 ± 20.5 < 0.001
Diet fiber, gram/1,000 kcal 5.96 ± 1.56 5.76 ± 1.39 4.48 ± 1.87 4.22 ± 1.82 < 0.001
BMI, body mass index; GDM, gestational diabetes mellitus; HDP, hypertensive disorders of pregnancy.
BMI for age Z-score and overweight/obesity in children were evaluated according to the age- and sex-specific growth reference issued by World Health Organization.
However, a US study showed that offspring of mothers with HDP
had a reduced Z score for BMI compared with children of non-
HDP mothers (32). This study also showed that children born
to mothers with GDM alone had a 1.5-fold increased risk for
overweight/obesity compared with children born tomothers with
normotension and normoglycaemia during pregnancy, and there
was no difference in odd ratio of overweight/obesity between
children born to mothers with GDM alone and those born to
mothers with HDP alone. Furthermore, although birth weight
was a risk factor for childhood obesity (8), children born to
HDP pregnancy had a lower or similar birth weight when
compared with the controls (18, 19, 32), implying the association
between maternal HDP and children’s obesity was complicated
and long lasting. Until now, very few studies have assessed
the joint association of maternal GDM and HDP with the
childhood obesity, and results remained unknown. Kvehaugen
and colleagues reported a non-significant higher proportion of
overweight or obesity in children of mothers with GDM or
preeclampsia than children of mothers without GDM and HDP
(33). The present study showed that children born to mothers
with joint GDM and HDP were associated with higher odds
ratios for overweight/obesity than those born to mothers with
normotension and normoglycaemia during pregnancy, and with
GDM alone.
The mechanism for the association of maternal GDM and
HDP with children’s overweight and obesity has not been fully
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understood. Shared familial genes and lifestyle may be the first
consideration as the reason of this association (20). However,
some researchers ascribed the mechanism to intrauterine
programming of epigenome. Data indicated that siblings who
were born to uncomplicated pregnancy had significantly lower
prevalence of obesity and vascular abnormalities than those born
to HDP- or GDM- complicated pregnancy (34, 35). Some studies
TABLE 2 | Comparison of BMI for age Z-score according to maternal gestational
diabetes and hypertensive disorders of pregnancy.
Non-GDM GDM P-value
Non-HDP HDP Non-HDP HDP
No. of subjects 677 27 1172 91
BMI for age
Z-score
Model 1
0.03 ± 0.05 0.55 ± 0.26* 0.27 ± 0.04† 0.63 ±
0.15†‡
<0.001
Model 2 0.03 ± 0.05 0.43 ± 0.25 0.27 ± 0.04† 0.60 ±
0.14†‡
<0.001
Model 3 0.05 ± 0.05 0.30 ± 0.25 0.28 ± 0.04† 0.46 ± 0.14* 0.002
Data were estimated means with SE or otherwise indicated.
GDM, gestational diabetes mellitus; HDP, hypertensive disorders of pregnancy.
*P < 0.05 compared with non-GDM and non-HDP group.
†
P < 0.001 compared with non-GDM and non-HDP group.
‡
P < 0.05 compared with GDM and non-HDP group.
Model 1: adjusted for maternal age at delivery, gestational age at delivery, education,
current smoking, history of insulin treatment of GDM, history of anti-hypertensive
treatment of HDP, and children’s age, sex, birth weight, and feeding status.
Model 2: adjusted for variables in Model 1 plus children’s outdoor physical activity time,
screen-watching time, sleep time, daily energy intake, dietary fiber intake and energy intake
from fat.
Model 3: adjusted for variables in Model 2 plus maternal pre-pregnancy BMI and
gestational weight gain.
also demonstrated that placental gene-specific hypomethylation
occurred more often in early-onset than late-onset pre-eclampsia
(36, 37). Further, amelioration of maternal GDM can help
reduce the odds ratio for children’s obesity (12). All these
clues supported intrauterine programming of epigenome in
the fetus, and implied the importance of early prevention,
management and treatment of metabolic disorder for next
generation’s health.
Insulin resistance may mediate GDM and HDP with
intrauterine programming of epigenome, because insulin
resistance was putative as pathogenesis of HDP and GDM in
pregnant women (38–41), and cord plasma insulin level was
positively associated with birth weight and neonatal fat mass
(42). We postulate that the combination of GDM and HDP
may imply more severe insulin resistance, as women with both
GDM and HDP had the higher level of pre-pregnancy BMI, a
parameter reflecting insulin resistance. This point of view needs
further investigation.
Our study enrolled a larger sample of GDM and non-GDM
mother-child pairs than previous studies. Data on a variety of
confounding variables, such as the parameters of mothers before
and during pregnancy; and indices of the children, including
birth weight, lifestyles factors, and anthropometric indexes were
collected and used in the final analysis. There were some
limitations in our study. First, maternal HDP, and children’s
diet intake, physical activity and sleeping time were based on
the self-reported questionnaire, which may bring retrospective
bias. However, good concordance between self-reported HDP
and clinical records has been validated in the United States and
England (43). Second, the sample size in only HDP group was
relatively small. Third, other confounders of children’s obesity,
such as the genetics, insulin resistance, have not been investigated
in the present study.
TABLE 3 | Odds ratios for childhood overweight according to maternal gestational diabetes and hypertensive disorders of pregnancy.
Odds ratios (95% confidence intervals) P for trend
Non-GDM GDM
Non-HDP HDP Non-HDP HDP
No. of participants 677 27 1172 91
No. of cases 115 7 279 33
Multivariable adjusted model 1 1.00 2.61 (0.98–6.93) 1.51 (1.17–1.95) 3.11 (1.78–5.43) <0.001
Multivariable adjusted model 2 1.00 2.13 (0.75–6.01) 1.48 (1.11–1.96) 2.97 (1.65–5.34) 0.001
Multivariable adjusted model 3 1.00 1.67 (0.57–4.94) 1.46 (1.09–1.96) 2.34 (1.28–4.27) 0.003
Additional analyses
Multivariable adjusted model 1 1.67 (0.63–4.42) 1 2.09 (1.23–3.54) 0.006
Multivariable adjusted model 2 1.39 (0.49–3.99) 1 2.06 (1.20–3.54) 0.009
Multivariable adjusted model 3 1.14 (0.38–3.45) 1 1.66 (0.95–2.90) 0.079
GDM, gestational diabetes mellitus; HDP, hypertensive disorders of pregnancy.
Overweight/obesity were defined as body mass index ≥85th percentile according to the age-, and sex-specific world health organization reference range in Children.
Model 1: adjusted for maternal age at delivery, gestational age at delivery, education, current smoking, history of insulin treatment of GDM, history of anti-hypertensive treatment of HDP,
and children’s age, sex, birth weight, and feeding status.
Model 2: adjusted for variables in Model 1 plus children’s outdoor physical activity time, screen-watching time, sleep time, daily energy intake, dietary fiber intake and energy intake
from fat.
Model 3: adjusted for variables in Model 2 plus maternal pre-pregnancy BMI and gestational weight gain.
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In conclusion, the present study indicated that maternal GDM
alone or joint GDM and HDP was associated with an increased Z
score for BMI-for-age and a higher risk of childhood overweight
in offspring. Maternal GDM and HDP had similar odds ratio
for children’s overweight. Joint maternal GDM and HDP were
associated with extra higher odds ratios of offspring’s overweight
than maternal GDM alone but this association was not fully
independent of maternal pre-pregnancy BMI and gestational
weight gain.
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